Recall Z-0458-2023— Intersect ENT, Inc.

Class II · Ongoing

Class II FDA medical device recall by Intersect ENT, Inc., initiated 2022-10-21. FDA's recall record names no specific 510(k) clearance for this event. Product: Propel Mini Mometasone Furoate Sinus Implant, with Straight Delivery System, REF 60044. Reason: Sinus Implant product label displays incorrect product information including: "Straight Delivery System", with incorrect reference number and UDI-DI..

Recalling firm
Intersect ENT, Inc.
Classification
Class II
Status
Ongoing
Initiated
2022-10-21
Firm location
Menlo Park, CA, United States

Product description

Propel Mini Mometasone Furoate Sinus Implant, with Straight Delivery System, REF 60044

Reason for recall

Sinus Implant product label displays incorrect product information including: "Straight Delivery System", with incorrect reference number and UDI-DI.

Data sourced from openFDA. This site is unofficial and independent of the FDA.